126 related articles for article (PubMed ID: 34528568)
1. Identification of potential targets with high centrality indicated by diethylnitrosamine + thioacetamide-induced hepatocellular carcinoma model.
Hora S; Asad M; Jain SK; Katare DP
J Cancer Res Ther; 2021; 17(4):1081-1092. PubMed ID: 34528568
[TBL] [Abstract][Full Text] [Related]
2. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
4. Impact of Mesenchymal Stem Cells and Vitamin D on Transforming Growth Factor Beta Signaling Pathway in Hepatocellular Carcinoma in Rats.
Saad El-Din S; Fouad H; Rashed LA; Mahfouz S; Hussein RE
Asian Pac J Cancer Prev; 2018 Apr; 19(4):905-912. PubMed ID: 29693337
[TBL] [Abstract][Full Text] [Related]
5. Multiple liver insults synergize to accelerate experimental hepatocellular carcinoma.
Henderson JM; Polak N; Chen J; Roediger B; Weninger W; Kench JG; McCaughan GW; Zhang HE; Gorrell MD
Sci Rep; 2018 Jul; 8(1):10283. PubMed ID: 29980757
[TBL] [Abstract][Full Text] [Related]
6. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
7. Dual regulating of mitochondrial fusion and Timp-3 by leflunomide and diallyl disulfide combination suppresses diethylnitrosamine-induced hepatocellular tumorigenesis in rats.
Abdel-Hamid NM; Abass SA; Eldomany RA; Abdel-Kareem MA; Zakaria S
Life Sci; 2022 Apr; 294():120369. PubMed ID: 35120919
[TBL] [Abstract][Full Text] [Related]
8. A novel chemoprotective effect of tiopronin against diethylnitrosamine-induced hepatocellular carcinoma in rats: Role of ASK1/P38 MAPK-P53 signalling cascade.
Mo'men YS; Hussein RM; Kandeil MA
Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):322-332. PubMed ID: 31663622
[TBL] [Abstract][Full Text] [Related]
9. An integrative analysis of chemically-induced cirrhosis-associated hepatocarcinogenesis: Histological, biochemical and molecular features.
Romualdo GR; Grassi TF; Goto RL; Tablas MB; Bidinotto LT; Fernandes AAH; Cogliati B; Barbisan LF
Toxicol Lett; 2017 Nov; 281():84-94. PubMed ID: 28943392
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
[TBL] [Abstract][Full Text] [Related]
11. Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma.
Park TJ; Kim HS; Byun KH; Jang JJ; Lee YS; Lim IK
Mol Carcinog; 2001 Mar; 30(3):138-50. PubMed ID: 11301474
[TBL] [Abstract][Full Text] [Related]
12. The molecular connection of histopathological heterogeneity in hepatocellular carcinoma: A role of Wnt and Hedgehog signaling pathways.
Tripathy A; Thakurela S; Sahu MK; Uthanasingh K; Behera M; Ajay AK; Kumari R
PLoS One; 2018; 13(12):e0208194. PubMed ID: 30513115
[TBL] [Abstract][Full Text] [Related]
13. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
14. Ellagic Acid Holds Promise Against Hepatocellular Carcinoma in an Experimental Model: Mechanisms of Action.
Zaazaa AM; Lokman MS; Shalby AB; Ahmed HH; El-Toumy SA
Asian Pac J Cancer Prev; 2018 Feb; 19(2):387-393. PubMed ID: 29479987
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma.
Qian C; Idoate M; Bilbao R; Sangro B; Bruña O; Vázquez J; Prieto J
Hum Gene Ther; 1997 Feb; 8(3):349-58. PubMed ID: 9048202
[TBL] [Abstract][Full Text] [Related]
16. Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats.
Saleem S; Kazmi I; Ahmad A; Abuzinadah MF; Samkari A; Alkrathy HM; Khan R
Nutr Cancer; 2020; 72(1):170-181. PubMed ID: 31088230
[No Abstract] [Full Text] [Related]
17. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
[TBL] [Abstract][Full Text] [Related]
19. Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver.
Lee TY; Kim KT; Han SY
Korean J Hepatol; 2007 Mar; 13(1):70-80. PubMed ID: 17380077
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
